Drug Shortage Report for MYLAN-NAPROXEN/ESOMEPRAZOLE MR

Last updated on 2020-11-03 History
Report ID 126401
Drug Identification Number 02443449
Brand name MYLAN-NAPROXEN/ESOMEPRAZOLE MR
Common or Proper name NAPROXEN/ESOMEPRAZOLE MR
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) NAPROXEN ESOMEPRAZOLE
Strength(s) 500MG 20MG
Dosage form(s) TABLET (IMMEDIATE AND DELAYED-RELEASE)
Route of administration ORAL ORAL
Packaging size 60BT
ATC code M01AE
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2020-12-23
Actual start date
Estimated end date 2020-12-29
Actual end date 2020-11-03
Shortage status Avoided shortage
Updated date 2020-11-03
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-11-03 French Compare
v3 2020-11-03 English Compare
v2 2020-10-15 French Compare
v1 2020-10-15 English Compare

Showing 1 to 4 of 4